Sanofi Cash Flow Statement Analysis

Operating, investing, and financing activities in billions EUR

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Sanofi (SNY) - Annual data in billions EUR
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income7.815.565.408.376.2212.29
Depreciation & Amortization3.213.594.433.053.003.19
Deferred Income Tax0.00-0.80-1.23-0.53-0.360.00
Stock Based Compensation0.000.280.260.230.240.27
Change in Working Capital0.00-0.620.41-0.791.41-0.33
Change in Accounts Receivable0.00-0.03-0.47-0.500.19-0.13
Change in Inventory0.00-0.48-0.87-0.92-0.36-0.59
Change in Accounts Payable0.000.790.260.340.450.09
Change in Other Working Capital0.000.140.310.281.130.32
Other Operating Activities-0.460.140.31-0.88-0.39-0.30
Net Cash from Operating Activities10.759.0810.2610.5310.527.42
Investing Activities
Capital Expenditures-1.86-3.20-2.91-1.53-1.48-1.25
Acquisitions0.00-2.52-2.67-0.99-5.59-5.34
Purchases of Investments0.00-0.62-0.13-0.35-0.2710.23
Sales/Maturities of Investments-1.76-1.46-1.29-0.57-0.57-0.83
Other Investing Activities0.43-0.11-1.250.03-0.07-0.11
Net Cash from Investing Activities-2.45-4.41-6.20-2.08-7.303.62
Financing Activities
Debt Repayment0.00-0.95-3.94-3.00-2.80-4.19
Common Stock Issued0.000.190.200.190.190.20
Common Stock Repurchased0.00-0.30-0.59-0.50-0.38-0.82
Dividends Paid0.00-4.70-4.45-4.17-4.01-3.94
Other Financing Activities-8.21-0.04-0.06-0.11-0.05-0.04
Net Cash from Financing Activities-8.21-5.76-8.05-5.82-7.06-6.49
Summary
Effect of Forex Changes on Cash-0.05-0.01-0.030.010.020.00
Net Change in Cash0.22-1.26-3.992.64-3.824.49
Cash at Beginning of Period7.448.7112.7410.1013.920.00
Cash at End of Period7.667.448.7112.7410.100.00
Free Cash Flow8.895.897.359.009.046.16
Supplemental Disclosures
Interest Paid0.000.590.560.380.330.32
Income Taxes Paid0.003.292.622.451.282.05